NCT02950259 2025-12-03Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)Providence Health & ServicesPhase 1 Completed16 enrolled 10 charts
NCT00001337 2025-06-22Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed348 enrolled 15 charts
NCT03267680 2025-04-13IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3University of Southern CaliforniaPhase 2 Terminated10 enrolled 19 charts